Suppr超能文献

通过在挤出滚圆法制备的微晶纤维素微丸中加入山梨醇或甘露醇来控制药物释放。

Control of drug release by incorporation of sorbitol or mannitol in microcrystalline-cellulose-based pellets prepared by extrusion-spheronization.

机构信息

Departamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.

出版信息

Pharm Dev Technol. 2010 Dec;15(6):626-35. doi: 10.3109/10837450903419653. Epub 2010 Feb 11.

Abstract

Mixtures of microcrystalline cellulose (MCC) with sorbitol (up to 50%) or mannitol (up to 80%) were investigated as major excipients for controlled accelerated release of the model poorly water-soluble drug hydrochlorothiazide from pellets prepared by extrusion/spheronization. Optimal wetting volume decreased with increasing polyol content and was always less than the volume required for maximum wet mass consistency. All pellet formulations had satisfactory morphological, mechanical and flow properties, although sorbitol/MCC pellets were rougher than mannitol/MCC pellets. Together they presented a wide range of drug release profiles in 0.1 M HCl, allowing the rate of drug release into aqueous media to be controlled by manipulation of sorbitol or mannitol content. Pellets with a 50% sorbitol content released hydrochlorothiazide faster than pellets with a 50% mannitol content because of their greater porosity and the greater solubility of sorbitol in water. Fastest release was from pellets with an 80% mannitol content, which rapidly underwent complete disintegration.

摘要

微晶纤维素 (MCC) 与山梨糖醇 (高达 50%) 或甘露醇 (高达 80%) 的混合物被用作通过挤出/球形化制备的模型难溶性药物氢氯噻嗪的控释微丸的主要赋形剂。随着多元醇含量的增加,最佳润湿体积减小,并且始终小于获得最大湿质量一致性所需的体积。尽管山梨糖醇/MCC 微丸比甘露醇/MCC 微丸更粗糙,但所有微丸制剂都具有令人满意的形态、机械和流动性能。它们共同提供了在 0.1 M HCl 中广泛的药物释放曲线,允许通过操纵山梨糖醇或甘露醇的含量来控制药物在水介质中的释放速率。由于其更大的孔隙率和山梨糖醇在水中的更高溶解度,含有 50%山梨糖醇的微丸比含有 50%甘露醇的微丸更快地释放氢氯噻嗪。释放最快的是含有 80%甘露醇的微丸,其迅速完全崩解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验